Pendal Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$78.8M Buy
465,171
+18,308
+4% +$3.32M 0.68% 62
2022
Q3
$83.6M Buy
+446,863
New +$94.2M 0.81% 45
2022
Q1
Sell
-1,100
Closed -$291K 558
2021
Q4
$291K Buy
+1,100
New +$296K ﹤0.01% 511
2021
Q1
Sell
-2,227
Closed -$427K 595
2020
Q4
$427K Buy
+2,227
New +$405K ﹤0.01% 393

Other funds holding RGEN

Pendal Group's RGEN Position: Q4 2022 in Review

Pendal Group increased its Repligen (RGEN) stake by 4.1% in Q4 2022, buying an estimated $3.32M and bringing the position to 465,171 shares worth $78.8M. The position accounts for 0.68% of the portfolio, ranked #62.

Pendal Group first reported a position in RGEN in Q4 2020 and has held it in 4 quarters since. The position peaked at $83.6M in Q3 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Pendal Group held 465,171 shares of Repligen worth $78.8M as of Q4 2022.
  • Pendal Group bought 18,308 Repligen shares in Q4 2022, an estimated $3.32M.
  • Repligen made up 0.68% of Pendal Group's portfolio in Q4 2022, its #62 holding.
  • Pendal Group first reported a position in Repligen in Q4 2020 and has held it in 4 quarters since.
  • Pendal Group's Repligen position peaked at $83.6M in Q3 2022.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.